Clin2
NCT07346079Possibly a fitRecruiting

Corticotropin gel for acute gout flares

Gout ArthritisGout FlareGout

Part of Bones, joints & muscles, Genetic & congenital, Hormones & metabolism clinical trials.

This study tests two doses of a medicine called Purified Cortrophin Gel for people having a gout flare that started in the last 5 days. It might be an option if other treatments haven't worked or aren't safe for you.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 4
Enrollment
150 people
Ages
18 years to 90 years
Study type
Interventional

Who can take part

  • You are between 18 and 85 years old.
  • Your current gout flare started within the last 5 days.
  • You have had at least one gout flare in the past 12 months.
  • Other standard gout treatments (like NSAIDs or colchicine) have not worked, caused side effects, or are not right for you.
  • You are willing to use a cellphone to complete surveys.
  • You are not pregnant, breastfeeding, or planning to become pregnant and are using effective contraception if needed.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07145229Recruiting· Phase 2
Testing a new drug for acute gout flares

This trial tests a new medication, ABP-745, for people having an acute gout flare. It aims to see if the drug is safe and helps reduce pain and inflammation.

Peoria, Arizona
NCT04875702Recruiting· Phase 4
Compare urate targets to reduce gout attacks or symptoms

This study compares two different treatment goals for a blood level called urate in people with gout. The goal is to see which approach lowers gout flares better while helping people feel better.

South Birmingham, Alabama
NCT07708181Not yet recruiting· Phase 2
SSGJ-613 injection for gout flare prevention

This trial tests an injection called SSGJ-613 to see if it can prevent gout flares in people who are starting a medication to lower uric acid. It's for people with frequent gout attacks.

NCT06863701Recruiting· Phase 3
Combination therapy for acute gout flare

This trial tests a combination of two medicines, etoricoxib and betamethasone, for quickly treating a painful gout flare. It is for people who have had gout before and whose current attack started within two days.

Mexico City
NCT07661030Not yet recruiting· Phase 4
Timing of dotinurad for gout flare relief

This trial tests whether starting dotinurad, a medication that lowers uric acid, at different times after a gout flare begins can help the flare resolve faster. It may help people with frequent or severe gout attacks find quicker relief.

NCT05658575Recruiting· Phase 2/Phase 3
Tablets to treat sudden gout flare pain

This trial studies dapansutrile tablets (OLT1177) to see how well they work for people in the first 4 days of an acute gout flare. It may help reduce pain and inflammation in the specific joint where your gout is flaring.

Birmingham, Alabama

Hear when a new Gout Arthritis trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.